Clinical Trial Update: Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer [NA]

View source ↗

Summary

The clinical trial evaluating stereotactic body radiotherapy for metastatic prostate cancer has been withdrawn from the study registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sharp HealthCare | Conditions: Metastatic Prostate Cancer | NA | Status: WITHDRAWN